Clustree raises €7M in Series A to bring artificial intelligence into human resources

News

Alven Capital which led Clustree’s first round 18 months ago is thrilled to announce that Clustree is raising a €7M Series A with Creandum and Idinvest Partner.

Alven Capital which led Clustree’s first round 18 months ago is thrilled to announce that Clustree is raising a €7M Series A with Creandum and Idinvest Partner.

Clustree offers artificial intelligence to to make internal and external HR data blind to stereotypes and human bias. The mission is to build a technology solution that delivers fact-based and proactive decision making for career development and recruitment.

With very limited sales and marketing resources, the company has been able to secure multi-year contracts with massive international enterprises. The solution is now used across 30 different countries by industry leaders such as Orange, Crédit Agricole, SNCF, Carrefour and L’Oréal, helping them to dramatically reduce external recruitment costs and increase employee retention.

In 2016, Clustree experienced 230% revenue growth and 100% client retention, and was named a Cool Vendor by Gartner which recognized that “Clustree is unique in that its usage of natural-language processing (NLP), machine learning and predictive analytics goes beyond talent acquisition to also support other talent mobility and HR topics.”

The €7m Series A funding will allow the company to develop its sales, marketing, engineering and product teams, consolidate its market position in France and prepare for international expansion.


Share

Skarlett Raises €8 Million Seed Round to Reinvent Personal Finance for the 60+ Generation

Skarlett, the marketplace dedicated to the financial needs of those over 60, today announces an €8 million seed funding round. The round…

Read

Carbon credits, built for business: Riverse €5M seed round

Riverse raised €5 million in seed funding to make carbon credits work for real companies and the real challenges they face. Alven…

Read

Okeiro raises €10 Million to accelerate development of its Precision Medicine platform for Transplantation and Chronic Diseases

Okeiro, a company specializing in precision medicine for transplantation and advanced chronic diseases, today announces a €10 million funding round to accelerate…

Read